China Medicine Corporation (CHME.OB) Reports Surge in Second Quarter Profit
China Medicine Corporation (CHME.OB), a developer and distributor of pharmaceuticals and nutritional supplements in China, reported strong second quarter financial results this morning. Revenues increased 40.8% year over year to $11.6 million, compared to $8.3 million in Q2 2007. Net income soared 118.8% to $2.5 million, or 16 cents per share, vs. $1.1 million, or 8 cents per share a year ago. No analysts currently cover the stock. Sales increased across the entire breadth of the company’s pharmaceutical portfolio. “We are pleased to report strong revenue growth driven by an increase in sales of pharmaceutical products through exclusive nationwide and…